Skip to main content

ADC Therapeutics SA

ADCT
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001771910

No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding ADC Therapeutics SA changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ADCT: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders8286+4
Shares54.8M68.0M+13.1M (+23.9%)
Value$77.3M$182.1M+$104.8M (+135.6%)

New holders (14)

Institutions that held ADC Therapeutics SA at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ADCT in Q2 2025
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.7,763,658$20.8M0.05%
Heights Capital Management, Inc2,832,861$7.59M2.38%
Nantahala Capital Management, LLC2,266,289$6.07M0.43%
StemPoint Capital LP283,286$759.2K0.24%
Virtu Financial LLC59,548$160.0K0.01%
Susquehanna Portfolio Strategies, LLC43,426$116.4K0.00%
Ethic Inc.37,862$102.6K0.00%
HRT Financial LP37,730$101.0K0.00%
Creative Planning35,999$96.5K0.00%
Citadel Advisors LLC29,006$77.7K0.00%
Simplex Trading, LLC7,350$19.0K0.00%
Jones Financial Companies LLLP3,000$8.13K0.00%
IFP Advisors, Inc30$800.00%
Essential Partners LLC24$640.00%

Sold out (10)

Institutions that held ADC Therapeutics SA at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of ADCT in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Two Sigma Investments, LP44,686$63.0K
Corebridge Financial, Inc.39,838$56.2K
SG Americas Securities, LLC23,878$34.0K
Atria Wealth Solutions, Inc.20,000$28.2K
CIBC World Markets Corp18,044$25.4K
Cerity Partners LLC17,912$25.3K
Lazard Asset Management LLC1,203$1.00K
Coldstream Capital Management Inc455$642
GoalVest Advisory LLC50$71
South State Corp.46$65